News
Idorsia Ltd (SIX: IDIA) announces the interim results of the repurchase offer for its outstanding CHF 204 * million convertible bonds maturing in 2025 (CB 2025; ISIN CH0426820350) and CHF 600 million ...
Announced on August 8, 2025, that the U.S. Food and Drug Administration (FDA) has approved the Genio® system for a subset of adult patients with moderate to severe OSA with an Apnea-Hypopnea Index ...
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results